ERBB2 and breast cancer: It has been demonstrated that STAT5A is required for expression of NADPH oxidase 5 long form (NOX5-L) in HER2-positive SK-BR-3 breast cancer cells where NOX5-L inhibition reduced proliferation, migration, and invasion [41].